These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35137177)

  • 1. Global spread of a Japan-originated Delta lineage of SARS-CoV-2 after the Tokyo Olympics is most likely unrelated to the Olympics.
    Shimura T; Kosaki K
    J Travel Med; 2022 Feb; ():. PubMed ID: 35137177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Preventive Strategies Adopted during Large Events on the COVID-19 Pandemic: A Case Study of the Tokyo Olympics to Provide Guidance for Future Large Events.
    Yao Y; Wang P; Zhang H
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tokyo Olympic Games and the Risk of COVID-19.
    Hoang VT; Al-Tawfiq JA; Gautret P
    Curr Trop Med Rep; 2020; 7(4):126-132. PubMed ID: 33145147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the impact of the Tokyo Olympics on COVID-19 cases using synthetic control methods.
    Esaka T; Fujii T
    J Jpn Int Econ; 2022 Dec; 66():101228. PubMed ID: 35990314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil.
    Romano CM; de Oliveira CM; da Silva LS; Levi JE
    Front Med (Lausanne); 2022; 9():930380. PubMed ID: 35783651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021.
    Yaglom HD; Maurer M; Collins B; Hojnacki J; Monroy-Nieto J; Bowers JR; Packard S; Erickson DE; Barrand ZA; Simmons KM; Brock BN; Lim ES; Smith S; Hepp CM; Engelthaler DM
    PLoS One; 2022; 17(10):e0272830. PubMed ID: 36315517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63.
    Moen LV; Vollan HS; Bråte J; Hungnes O; Bragstad K
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from the COVID-19 control strategy of the XXXII Tokyo Summer Olympics and the XXIV Beijing Winter Olympics.
    Zhang Y; Ai J; Bao J; Zhang W
    Emerg Microbes Infect; 2022 Dec; 11(1):1711-1716. PubMed ID: 35726527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are mega-events super spreaders of infectious diseases similar to COVID-19? A look into Tokyo 2020 Olympics and Paralympics to improve preparedness of next international events.
    Chowdhury T; Chowdhury H; Bontempi E; Coccia M; Masrur H; Sait SM; Senjyu T
    Environ Sci Pollut Res Int; 2023 Jan; 30(4):10099-10109. PubMed ID: 36066799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not all fun and games: Potential incidence of SARS-CoV-2 infections during the Tokyo 2020 Olympic Games.
    Linton NM; Jung SM; Nishiura H
    Math Biosci Eng; 2021 Nov; 18(6):9685-9696. PubMed ID: 34814363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.
    Arantes I; Gomes Naveca F; Gräf T; ; Miyajima F; Faoro H; Luz Wallau G; Delatorre E; Reis Appolinario L; Cavalcante Pereira E; Venas TMM; Sampaio Rocha A; Serrano Lopes R; Mendonça Siqueira M; Bello G; Cristina Resende P
    Microbiol Spectr; 2022 Oct; 10(5):e0264121. PubMed ID: 36000897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
    Jung SM; Hayashi K; Kayano T; Nishiura H
    Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Border Transmissions of the Delta Substrain AY.29 During Tokyo Olympic and Paralympic Games.
    Koyama T; Tokumasu R; Katayama K; Saito A; Kudo M; Imoto S
    Front Microbiol; 2022; 13():883849. PubMed ID: 35992703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021.
    Ito K; Piantham C; Nishiura H
    Euro Surveill; 2021 Jul; 26(27):. PubMed ID: 34240695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.
    Prasetyoputri A; Dharmayanthi AB; Iryanto SB; Andriani A; Nuryana I; Wardiana A; Ridwanuloh AM; Swasthikawati S; Hariyatun H; Nugroho HA; Idris I; Indriawati I; Noviana Z; Oktavia L; Yuliawati Y; Masrukhin M; Hasrianda EF; Sukmarini L; Fahrurrozi F; Yanthi ND; Fathurahman AT; Wulandari AS; Setiawan R; Rizal S; Fathoni A; Kusharyoto W; Lisdiyanti P; Ningrum RA; Saputra S
    PeerJ; 2022; 10():e13132. PubMed ID: 35341058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo.
    Tani-Sassa C; Iwasaki Y; Ichimura N; Nagano K; Takatsuki Y; Yuasa S; Takahashi Y; Nakajima J; Sonobe K; Nukui Y; Takeuchi H; Tanimoto K; Tanaka Y; Kimura A; Tohda S
    J Med Virol; 2022 Apr; 94(4):1707-1710. PubMed ID: 34825717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity.
    Tsuchiya K; Yamamoto N; Hosaka Y; Wakita M; Hiki M; Matsushita Y; Mori H; Hori S; Misawa S; Miida T; Nojiri S; Takahashi K; Naito T; Tabe Y
    Front Microbiol; 2022; 13():912061. PubMed ID: 35966679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan.
    Yan Y; Naito T; Tabe Y; Ito K; Nojiri S; Deshpande GA; Seyama K; Takahashi K
    Vaccine; 2022 May; 40(23):3103-3108. PubMed ID: 35465978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
    Azami NAM; Perera D; Thayan R; AbuBakar S; Sam IC; Salleh MZ; Isa MNM; Ab Mutalib NS; Aik WK; Suppiah J; Tan KK; Chan YF; Teh LK; Azzam G; Rasheed ZBM; Chan JCJ; Kamel KA; Tan JY; Khalilur Rahman O; Lim WF; Johari NA; Ishak M; Yunos RIM; Anasir MI; Wong JE; Fu JYL; Noorizhab MNF; Sapian IS; Mokhtar MFM; Md Shahri NAA; Ghafar K; Yusuf SNHM; Noor YM; Jamal R;
    Int J Infect Dis; 2022 Dec; 125():216-226. PubMed ID: 36336246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico.
    Taboada B; Zárate S; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Boukadida C; Gómez-Gil B; Selem Mojica N; Rosales-Rivera M; Salas-Lais AG; Gutiérrez-Ríos RM; Loza A; Rivera-Gutierrez X; Vazquez-Perez JA; Matías-Florentino M; Pérez-García M; Ávila-Ríos S; Hurtado JM; Herrera-Nájera CI; Núñez-Contreras JJ; Sarquiz-Martínez B; García-Arias VE; Santiago-Mauricio MG; Martínez-Miguel B; Enciso-Ibarra J; Cháidez-Quiróz C; Iša P; Wong-Chew RM; Jiménez-Corona ME; López S; Arias CF
    Viruses; 2022 May; 14(6):. PubMed ID: 35746637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.